Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma

Chemical Research in Toxicology

Volumn 9, Issue 3, 1996, Pages 659-666

  Bailey, Mark J ^a   Dickinson, Ronald G ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTILIPEMIC AGENT; CARBOXYLIC ACID DERIVATIVE; CLOFIBRATE; DIFLUNISAL; GLUCURONIDE; NONSTEROID ANTIINFLAMMATORY AGENT; VALPROIC ACID; ZOMEPIRAC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG GLUCURONIDATION; DRUG LIVER LEVEL; DRUG PROTEIN BINDING; IMMUNOBLOTTING; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTILIPEMIC AGENTS; BLOOD PROTEINS; CARBOXYLIC ACIDS; CLOFIBRIC ACID; DIFLUNISAL; GLUCURONATES; IMMUNOBLOTTING; LIVER; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEINS; RABBITS; RATS; TOLMETIN; VALPROIC ACID;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0029863135     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx960017o     Document Type: Article

References (49)

1. Faed, E. M. (1984) Properties of acyl glucuronides: Implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab. Rev. 15, 1213-1249.
2. Spahn-Langguth, H., and Benet, L. Z. (1992) Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab. Rev. 24, 5-47.
3. Dickinson, R. G. (1993) Acyl glucuronide conjugates: reactive metabolites of nonsteroidal anti-inflammatory drugs. Proc. Western Pharmacol. Soc. 36, 157-162.
4. Fenselau, C. (1994) Acyl glucuronides as chemically reactive intermediates. Handb. Exp. Pharmacol. 112, 367-389.
5. Ding, A., Ojingwa, J. C., McDonagh, A. F., Burlingame, A. L., and Benet, L. Z. (1993) Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry. Proc. Natl. Acad. Sci. U.S.A. 90, 3797-3801.
6. Williams, A. M., and Dickinson, R. G. (1994) Studies on the reactivity of acyl glucuronides - VI. Modulation of reversible and covalent interaction of diflunisal acyl glucuronide and its isomers with human plasma protein in vitro. Biochem. Pharmacol. 47, 457-467.
7. Ding, A., Zia-Amirhosseini, P., McDonagh, A. F., Burlingame, A. L., and Benet, L. Z. (1995) Reactivity of tolmetin glucuronide with human serum albumin: Identification of binding sites and mechanisms of reaction by tandem mass spectrometry. Drug Metab. Dispos 23, 369-376.
8. Smith, P. C., McDonagh, A. F., and Benet, L. Z. (1986) Irreversible binding of zomepirac to plasma protein in vitro and in vivo. J. Clin. Invest. 77, 934-939.
9. Hyneck, M. L., Smith, P. C., Munafo, A., McDonagh, A. F., and Benet, L. Z. (1988) Disposition and irreversible plasma protein binding of tolmetin in humans. Clin. Pharmacol. Ther. 44, 107-114.
10. McKinnon, G. E., and Dickinson, R. G. (1989) Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation. Res. Commun. Chem. Pathol. Pharmacol. 66, 339-354.
11. Iwakawa, S., Spahn, H., Benet, L. Z., and Lin, E. T. (1990) Stereoselective binding of the glucuronide conjugates of carpofen enantiomers to human serum albumin. Biochem. Pharmacol. 39, 949-953.
12. Volland, C., Sun, H., Dammeyer, J., and Benet, L. Z. (1991) Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein. Drug Metab. Dispos. 19, 1080-1086.
13. Sallustio, B. C., Knights, K. M., Roberts, B. J., and Zacest, R. (1991) In vivo covalent binding of clofibric acid to human plasma proteins and rat liver proteins. Biochem. Pharmacol. 42, 1421-1425.
14. Williams, A. M., de Jersey, J., Worrall, S., and Dickinson, R. G. (1992) Studies on the reactivity of acyl glucuronides - III. Glucuronide-derived adducts of valproic acid and plasma protein and anti-adduct antibodies in humans. Biochem. Pharmacol. 43, 745-755.
15. Benet, L. Z., Spahn-Langguth, H., Iwakawa, S., Volland, C., Mizuma, T., Mayer, S., Mutschler, E., and Lin, E. T. (1993) Predictability of the covalent binding of acidic drugs in man. Life Sci. 53, 141-146.
16. King, A. R., and Dickinson, R. G. (1993) Studies on the reactivity of acyl glucuronides - IV. Covalent binding of diflunisal to tissues of the rat. Biochem. Pharmacol. 45, 1043-1047.
17. Dickinson, R. G., and King, A. R. (1993) Studies on the reactivity of acyl glucuronides - V. Glucuronide-derived covalent binding of diflunisal to bladder tissue of rats and its modulation by urinary pH and β-glucuronidase Biochem. Pharmacol. 46, 1175-1182.
18. Hargus, S. J., Amouzedeh, H. R., Pumford, N. R., Myers, T. G., McCoy, S. C., and Pohl, L. R. (1994) Metabolic activation and immunochemical localization of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol. 7, 575-582.
19. Kretz-Rommel, A., and Boelsterli, U. A. (1994) Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: Radiochemical and immunochemieal analysis. Mol. Pharmacol. 45, 237-244.
20. Zia-Amirhosseini, P., Harris, R. Z., Brodsky, F. M., and Benet, L. Z. (1995) Hypersensitivity to nonsteroidal anti-inflammatory drugs. Nat. Med. 1, 2-4.
21. Worrall, S., and Dickinson, R. G. (1995) Rat serum albumin modified by diflunisal acyl glucuronide is immunogenic in rats. Life Sci 56, 1921-1930.
22. Cook, D. J., Achong, M. R., and Murphy, F. R. (1988) Three cases of diflunisal hypersensitivity. Can. Med. Assoc. J. 138, 1029-1030.
23. Zimmerman, H. J. (1990) Update of hepatotoxicity due to classes of drugs in common clinical use: nonsteroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents. Semin. Liver Dis. 10, 322-338.
24. Eadie, M J., Hooper, W. D., and Dickinson, R G. (1988) Valproate-associated hepatotoxicity and its biochemical mechanisms. Med. Toxicol 3, 85-106.
25. Smith, P. C , Hasegawa, J., Langendijk, P. N J., and Benet, L. Z. (1985) Stability of acyl glucuronides in blood, plasma and urine: studies with zomepirac. Drug Metab. Dispos. 13, 110-112.
26. Watt, J. A., and Dickinson, R G. (1990) Reactivity of diflunisal acyl glucuronide in human and rat plasma and albumin solutions. Biochem. Pharmacol. 39, 1067-1075.
27. Hayase, F., Nagaraj, R. H., Miyata, S., Njoroge, F. G., and Monnier, V. M. (1989) Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J. Biol. Chem. 264, 3758-3764.
28. Williams, A. M., Worrall, S., De Jersey, J., and Dickinson, R. G. (1995) Studies on the reactivity of acyl glucuronides - VIII. Generation of an antiserum for the detection of diflunisal-modified proteins in diflunisal-dosed rats. Biochem. Pharmacol. 49, 209-217.
29. Dickinson, R. G., Harland, R. C., Ilias, A. M., Rodgers, R. M., Kaufman, S. N., Lynn, R. K., and Gerber, N. (1979) Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. J. Pharmacol. Exp. Ther. 211, 583-595.
30. Dickinson, R. G., and King, A. R. (1989) Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal. Ther. Drug Monit. 11, 712-720.
31. Dickinson, R. G., Hooper, W. D., Dunstan, P. R., and Eadie, M. J. (1989) Urinary excretion of valproate and some metabolites in chronically treated patients. Ther. Drug Monit. 11, 127-133.
32. Tsang, V. C., Peralta, J. M., and Simons, A. R. (1983) Enzyme-linked immunotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies. Methods Enzymol. 92, 377-391.
33. Hirom, P. C., Millburn, P., and Smith, R. L. (1976) Bile and urine as complementary pathways for the excretion of foreign organic compounds. Xenobiotica 6, 55-64.
34. Klaassen, C. D., and Watkins, J. B. (1984) Mechanisms of bile formation, hepatic uptake and biliary excretion. Pharmacol. Rev. 36, 1-67.
35. Dickinson, R. G., King, A. R., and Verbeeck, R. K. (1989) Elimination of diflunisal as its acyl glucuronide, phenolic glucuronide and sulfate conjugates in bile-exteriorized and intact rats. Clin. Exp. Pharmacol. Physiol. 16, 913-924.
36. Emudianughe, T. S., Caldwell, J., Sinclair, K. A., and Smith, R. L. (1983) Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man. Drug Metab. Dispos. 11, 97-102.
37. Grindel, J. M., O'Neill, P. J., Yorgey, K. A., Schwartz, M. H., McKown, L. A., Migdalof, B. H., and Wu, W.-N. (1980) The metabolism of zomepirac sodium I. Disposition in laboratory animals and man. Drug Metab. Dispos. 8, 343-348.
38. Wu, W. N., Weaner, L. E., Kalbron, J., O'Neill, P. J., and Grindel, J. M. (1980). The metabolism of zomepirac sodium II. Isolation and identification of the urinary metabolites in rat, mouse, rhesus monkey and man. Drug Metab. Dispos. 8, 349-352.
39. Van Breeman, R. B., and Fenselau, C. (1985) Acylation of albumin by 1-O-acyl glucuronides. Drug Metab. Dispos. 13, 318-320
40. Hertz, R., and Bar-Tana, J. (1988) The acylation of proteins by xenobiotic amphipathic carboxylic acids in cultured rat hepatocytes. Biochem. J. 254, 39-44.
41. Heinemeyer, G , Nau, H., Hildebrandt, A. G., and Roots, I. (1985) Oxidation and glucuronidation of valproic acid in male rats - Influence of phenobarbital, 3-methylchloranthrane, β-naptholflavone and clofibrate. Biochem. Pharmacol. 34, 133-139.
42. Porubek, D. J., Grillo, M P., and Baillie, T. A. (1989) The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes. Drug Metab. Dispos. 17, 123-130.
43. Kassahun, K., Hu, P., Grillo, M. P., Davis, M. R., Jin, L., and Baillie, T. A. (1994) Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes. Chem.-Biol Interact. 90, 253-275.
44. Tang, W., Borel, A. G., Fujimiya, T., and Abbott, F. S. (1995) Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status. Chem. Res. Toxicol. 8, 671-682.
45. Pumford, N. R., Myers, T. G., Davila, J. C., Highet, R. J., and Pohl, L. R. (1993) Immunochemical detection of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol. 6, 147-150.
46. Hargus, S. J., Martin, B. M., George, J. W., and Pohl, L. R. (1995) Covalent modification of rat Liver dipeptidyl peptidase IV (CD26) by the nonsteroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol. 8, 993-996.
47. Kretz-Rommel, A., and Boelsterli, U. A. (1993) Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes. Toxicol. Appl. Pharmacol. 120, 155-161.
48. Kretz-Rommel, A., and Boelsterli, U. A. (1994) Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct. Drug Metab. Dispos. 22, 956-961.
49. Matsubara, Y., Kraus, J. P., Ozasa, H., Glassberg, R., Finocchiaro, G., Ikeda, Y., Mole, J., Rosenberg, L. E., and Tanaka, K. (1987) Molecular cloning and nucleotide sequence of cDNA encoding the entire precursor of rat liver medium chain acyl coenzyme A dehydrogenase. J. Biol. Chem. 262, 10104-10108.